MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
批准号:
2672187
负责人:
Haval Shirwan
金额:
$2.05万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 1998-11-30
关键词:
CD antigens T cell receptor T lymphocyte flow cytometry heart transplantation histocompatibility antigens homologous transplantation hybridomas laboratory rat major histocompatibility complex monoclonal antibody polymerase chain reaction synthetic peptide tissue /cell culture transplant rejection transplantation immunology
中文摘要
本研究建议的主要目标是确定
参与免疫识别过程的分子成分
同种异体移植排斥反应。 移植物排斥反应是由T细胞启动的,
受体通过克隆识别外来移植物的抗原,
表达的TCR。 这个认知过程的基础是
由TCR、MHC分子组成的三分子复合物(所述三分子复合物的
受体和/或供体类型),和代谢上来源于
处理过的移植物抗原 免疫过程中这种复合物的形成
对移植物的反应引发了一系列细胞内和细胞间的
导致移植物破坏的反应。 因此,澄清
三分子复合物的性质和随后的事件
不仅能拓宽我们对移植排斥反应的理解
排斥过程,但也可能提供一种手段,以诱导移植-
具体宽容。
该提案的具体目标包括:
1. 由分离自人的GIL的TCR库使用的表征
在不同的大鼠品系组合中进行心脏同种异体移植,
一系列组织相容性抗原。
2. 从具有特异性的GIL建立T细胞系和/或克隆
对移植物抗原的反应性及其在介导
过继移植后的心脏移植排斥反应
3.作为移植物靶点的移植物抗原的鉴定
反应性T细胞及其在排斥反应中的作用分析
反应
英文摘要
The primary objectives of this research proposal are to identify the
molecular components of the immune recognition process involved in
allograft rejection. Graft rejection is initiated by T cells of the
recipient recognizing antigens of the foreign graft through clonally-
expressed TCRs. The basis of this recognition process is the formation
of a trimolecular complex consisting of the TCR, MHC molecule (of the
recipient and/or donor type), and a peptide derived from metabolically
processed graft antigens. The formation of this complex during immune
response to the graft initiates a set of intra- and intercellular
reactions that result in destruction of the graft. Hence, elucidation
of the nature of the trimolecular complex and the subsequent events
involved in the graft rejection will not only broaden our understanding
of the rejection process, but may also provide a means to induce graft-
specific tolerance.
The Specific Aims of this proposal include:
1. Characterization of the TCR repertoire usage by GILs isolated from
cardiac allografts performed in rat strain combinations disparate for
range of histocompatibility antigens.
2. Establishment of T-cell lines and/or clones from GILs with specific
reactivity to graft antigens and examination of their role in mediating
cardiac graft rejection following adoptive transfer.
3. Identification of graft antigens that serve as targets for graft-
reactive T cells and the analysis of their role in the rejection
reaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel immunomodulatory approach to overcome innate and adaptiveimmune barriers to islet transplantation
-
批准号:10289717
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2018
-
负责人:Haval Shirwan
-
依托单位:
Developing a novel adjuvant system for therapeutic vaccines against lung cancer
-
批准号:9138899
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2016
-
负责人:Haval Shirwan
-
依托单位:
Engineering pancreatic islets with TGβ protein to overcome rejection
-
批准号:9066573
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2015
-
负责人:Haval Shirwan
-
依托单位:
Engineering pancreatic islets with TGβ protein to overcome rejection
-
批准号:8966928
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:Haval Shirwan
-
依托单位:
ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy
-
批准号:7326239
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2007
-
负责人:Haval Shirwan
-
依托单位:
A Novel Approach to Prevent and Treat Type 1 Diabetes
-
批准号:7096113
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2004
-
负责人:Haval Shirwan
-
依托单位:
A NOVEL ADJUVANT FOR TUMQR VACCINATION
-
批准号:6735511
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:Haval Shirwan
-
依托单位:
A Novel Approach to Prevent and Treat Type 1 Diabetes
-
批准号:6821845
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2004
-
负责人:Haval Shirwan
-
依托单位:
APOPTOSIS:A MEANS OF IMMUNE REGULATION TO TREAT DIABETES
-
批准号:6352400
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
APOPTOSIS:A MEANS OF IMMUNE REGULATION TO TREAT DIABETES
-
批准号:6612650
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6621531
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6681866
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6828262
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
APOPTOSIS:A MEANS OF IMMUNE REGULATION TO TREAT DIABETES
-
批准号:6525243
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6434813
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2413634
-
项目类别:
-
资助金额:$11.32万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068641
-
项目类别:
-
资助金额:$8.76万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068638
-
项目类别:
-
资助金额:$11.1万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068639
-
项目类别:
-
资助金额:$5.73万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068640
-
项目类别:
-
资助金额:$4.24万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
海外基金